What is the typical location of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

NSAID-Induced Gastric Ulcer Location

NSAID-induced gastric ulcers occur predominantly in the stomach (gastric) rather than the duodenum, with gastric ulcers being more common than duodenal ulcers in NSAID users.

Location Distribution

The evidence consistently demonstrates that NSAIDs preferentially cause gastric ulcers over duodenal ulcers 1. Endoscopic studies show that approximately 10-30% of regular NSAID users develop gastric ulcers, while gastric erosions and subepithelial hemorrhages are found in roughly half of patients taking NSAIDs regularly 1.

Key Anatomical Patterns:

  • Gastric ulcers are the predominant lesion - These occur more frequently than duodenal ulcers in NSAID users 2
  • Gastric erosions and petechiae - These superficial lesions are extremely common, appearing in approximately 50% of regular NSAID users 1
  • Duodenal ulcers occur less frequently - While NSAIDs can cause duodenal ulcers, they are less common than gastric lesions 2

Beyond the Upper GI Tract

An important but underappreciated finding is that NSAIDs also cause nonspecific small intestinal ulceration. A landmark postmortem study found small intestinal ulcers in 8.4% of NSAID users compared to only 0.6% of non-users 3. These small bowel ulcers, though less common than gastroduodenal lesions, can lead to life-threatening complications including perforation 3.

Clinical Implications

The gastric predominance of NSAID ulcers has important therapeutic implications:

  • H2-receptor antagonists prevent duodenal ulcers but are ineffective for gastric ulcers 2
  • Misoprostol is proven to decrease gastric ulcer risk and is the only FDA-approved agent for prevention of NSAID-induced gastric ulcers 4, 2
  • Proton pump inhibitors (PPIs) are the preferred agents for both therapy and prophylaxis of NSAID-associated GI injury, as they effectively address both gastric and duodenal lesions 4

Critical Caveat

The lack of correlation between symptoms and endoscopic findings means that serious complications like bleeding and perforation frequently occur in asymptomatic patients 2. Upper abdominal symptoms do not reliably predict the presence or location of NSAID-induced ulcers 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.